News

Whiteboards were adapted to ambulatory care areas as a communication tool similar to their use in the inpatient setting.
The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).
Researchers studied the relationship between lymphovascular invasion and adverse outcomes in patients with cutaneous squamous cell carcinoma.
A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as p ...
Most patients experienced at least 10 symptoms and at least one aspect of emotional impact, such as worry, depression, or anxiety.
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations.
Postoperative complication rates after mastectomy are higher in older women, but with careful selection and assessment, they may still be a candidate for immediate breast reconstruction.
Researchers sought to determine whether a reduced dose of apixaban would be as effective as using full-dose apixaban in preventing recurrent VTE in patients with active cancer.
Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.
Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.
Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...
Analysis of symptoms experienced by adolescents with cancer receiving chemotherapy were identified by prevalence, severity, and distress, and categorized into specific symptom clusters.